{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T20:40:27Z","timestamp":1728852027738},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,13]]},"DOI":"10.7759\/cureus.71376","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T20:08:53Z","timestamp":1728850133000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between Thrombin Generation and Hepatic Fibrosis in Chronic Liver Diseases"],"prefix":"10.7759","author":[{"given":"Liliana","family":"Vecerzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionela","family":"Maniu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Cioca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1727116","article-title":"Thrombin: a pivotal player in hemostasis and beyond","volume":"47","author":"Larsen JB","year":"2021","unstructured":"Larsen JB, Hvas AM. Thrombin: a pivotal player in hemostasis and beyond. Semin Thromb Hemost. 2021, 47:759-74. 10.1055\/s-0041-1727116","journal-title":"Semin Thromb Hemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040562","article-title":"Role of thrombin in central nervous system injury and disease","volume":"11","author":"Shlobin NA","year":"2021","unstructured":"Shlobin NA, Har-Even M, Itsekson-Hayosh Z, Harnof S, Pick CG. Role of thrombin in central nervous system injury and disease. Biomolecules. 2021, 11:562. 10.3390\/biom11040562","journal-title":"Biomolecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00876-7","article-title":"The contact system in liver injury","volume":"43","author":"Rangaswamy C","year":"2021","unstructured":"Rangaswamy C, Mailer RK, Englert H, Konrath S, Renn\u00e9 T. The contact system in liver injury. Semin Immunopathol. 2021, 43:507-17. 10.1007\/s00281-021-00876-7","journal-title":"Semin Immunopathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.150748","article-title":"Coagulation and fibrosis in chronic liver disease","volume":"57","author":"Calvaruso V","year":"2008","unstructured":"Calvaruso V, Maimone S, Gatt A, Tuddenham E, Thursz M, Pinzani M, Burroughs AK. Coagulation and fibrosis in chronic liver disease. Gut. 2008, 57:1722-7. 10.1136\/gut.2008.150748","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084201","article-title":"Berberine effects in pre-fibrotic stages of non-alcoholic fatty liver disease-clinical and pre-clinical overview and systematic review of the literature","volume":"25","author":"Ionita-Radu F","year":"2024","unstructured":"Ionita-Radu F, Patoni C, Nancoff AS, et al.. Berberine effects in pre-fibrotic stages of non-alcoholic fatty liver disease-clinical and pre-clinical overview and systematic review of the literature. Int J Mol Sci. 2024, 25:4201. 10.3390\/ijms25084201","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis: from the bench to clinical targets","volume":"36","author":"Pinzani M","year":"2004","unstructured":"Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004, 36:231-42. 10.1016\/j.dld.2004.01.003","journal-title":"Dig Liver Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis - from bench to bedside","volume":"38","author":"Friedman SL","year":"2003","unstructured":"Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol. 2003, 38:S38-53. 10.1016\/S0168-8278(02)00429-4","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1042\/CS20060242","article-title":"Liver fibrosis: cellular mechanisms of progression and resolution","volume":"112","author":"Henderson NC","year":"2007","unstructured":"Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond). 2007, 112:265-80. 10.1042\/CS20060242","journal-title":"Clin Sci (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6932","article-title":"The HMGB1\u2011RAGE\/TLR\u2011TNF\u2011\u03b1 signaling pathway may contribute to kidney injury induced by hypoxia","volume":"17","author":"Zhang C","year":"2019","unstructured":"Zhang C, Dong H, Chen F, Wang Y, Ma J, Wang G. The HMGB1\u2011RAGE\/TLR\u2011TNF\u2011\u03b1 signaling pathway may contribute to kidney injury induced by hypoxia. Exp Ther Med. 2019, 17:17-26. 10.3892\/etm.2018.6932","journal-title":"Exp Ther Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.715111","article-title":"Plasma kallikrein as a modulator of liver injury\/remodeling","volume":"12","author":"Ahmed IA","year":"2021","unstructured":"Ahmed IA, Jaffa MA, Moussa M, et al.. Plasma kallikrein as a modulator of liver injury\/remodeling. Front Pharmacol. 2021, 12:715111. 10.3389\/fphar.2021.715111","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i18.4427","article-title":"Thrombin activation and liver inflammation in advanced hepatitis C virus infection","volume":"22","author":"Gonz\u00e1lez-Reimers E","year":"2016","unstructured":"Gonz\u00e1lez-Reimers E, Quintero-Platt G, Mart\u00edn-Gonz\u00e1lez C, P\u00e9rez-Hern\u00e1ndez O, Romero-Acevedo L, Santolaria-Fern\u00e1ndez F. Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol. 2016, 22:4427-37. 10.3748\/wjg.v22.i18.4427","journal-title":"World J Gastroenterol"},{"key":"ref12","article-title":"Global test of hemostasis: thrombin generation assay","volume":"135","author":"Olteanu LA","year":"2015","unstructured":"Olteanu LA, Mihalache M, Mihaila RG. Global test of hemostasis: thrombin generation assay. Clinical Aspects. 2015, 135:135-8.","journal-title":"Clinical Aspects"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1515\/rrlm-2016-0026","article-title":"Evaluation of thrombin generation in classical Philadelphia negative myeloproliferative neoplasms","volume":"24","author":"Olteanu AL","year":"2016","unstructured":"Olteanu AL, Mih\u0103il\u0103 RG, and Mihalache M. Evaluation of thrombin generation in classical Philadelphia negative myeloproliferative neoplasms. Revista Romana de Medicina de Laborator. 2016, 24:279-89. 10.1515\/rrlm-2016-0026","journal-title":"Revista Romana de Medicina de Laborator"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.55453\/rjmm.2015.118.2.1","article-title":"From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease,","volume":"118","author":"Diaconu C","year":"2015","unstructured":"Diaconu C , Ioni\u021b\u0103 Radu F, Jinga M, et al.. From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease,. Romanian Journal of Military Medicine. 2015, 118:5-12. 10.55453\/rjmm.2015.118.2.1","journal-title":"Romanian Journal of Military Medicine"},{"key":"ref15","article-title":"Use of the Child Pugh score In liver disease","author":"Tsoris A","year":"2023","unstructured":"Tsoris A, Marlar CA. Use of the Child Pugh score In liver disease. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23270","article-title":"The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B","volume":"34","author":"Zhong LK","year":"2020","unstructured":"Zhong LK, Zhang G, Luo SY, Yin W, Song HY. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B. J Clin Lab Anal. 2020, 34:e23270. 10.1002\/jcla.23270","journal-title":"J Clin Lab Anal"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.498","article-title":"Changing concepts of cirrhotic coagulopathy","volume":"112","author":"Tripodi A","year":"2017","unstructured":"Tripodi A, Primignani M, Mannucci PM, Caldwell SH. Changing concepts of cirrhotic coagulopathy. Am J Gastroenterol. 2017, 112:274-81. 10.1038\/ajg.2016.498","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata NM","year":"2019","unstructured":"Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 2019, 156:1582-99.e1. 10.1053\/j.gastro.2019.01.265","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1550430","article-title":"Rebalanced hemostasis in patients with acute liver failure","volume":"41","author":"Lisman T","year":"2015","unstructured":"Lisman T, Stravitz RT. Rebalanced hemostasis in patients with acute liver failure. Semin Thromb Hemost. 2015, 41:468-73. 10.1055\/s-0035-1550430","journal-title":"Semin Thromb Hemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2017.12.017","article-title":"Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium","volume":"225","author":"Huebner BR","year":"2018","unstructured":"Huebner BR, Moore EE, Moore HB, et al.. Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium. J Surg Res. 2018, 225:1-5. 10.1016\/j.jss.2017.12.017","journal-title":"J Surg Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.03.017","article-title":"In\u00a0vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation","volume":"21","author":"Elvers FL","year":"2023","unstructured":"Elvers FL, Stamouli M, Adelmeijer J, et al.. In\u00a0vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation. J Thromb Haemost. 2023, 21:2078-88. 10.1016\/j.jtha.2023.03.017","journal-title":"J Thromb Haemost"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12173","article-title":"Liver stiffness and thrombin generation in compensated cirrhosis","volume":"3","author":"Dillon A","year":"2019","unstructured":"Dillon A, Egan K, Kevane B, Galvin Z, Maguire P, N\u00ed \u00c1inle F, Stewart S. Liver stiffness and thrombin generation in compensated cirrhosis. Res Pract Thromb Haemost. 2019, 3:291-7. 10.1002\/rth2.12173","journal-title":"Res Pract Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.09.007","article-title":"Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study","volume":"207","author":"Brodard J","year":"2021","unstructured":"Brodard J, Calzavarini S, Quarroz C, Berzigotti A, De Gottardi A, Angelillo-Scherrer A. Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study. Thromb Res. 2021, 207:40-9. 10.1016\/j.thromres.2021.09.007","journal-title":"Thromb Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100120","article-title":"Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis","volume":"2","author":"Zermatten MG","year":"2020","unstructured":"Zermatten MG, Fraga M, Calderara DB, Aliotta A, Moradpour D, Alberio L. Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis. JHEP Rep. 2020, 2:100120. 10.1016\/j.jhepr.2020.100120","journal-title":"JHEP Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9050550","article-title":"Thrombin generation in chronic liver diseases - a pilot study","volume":"9","author":"Vecerzan L","year":"2021","unstructured":"Vecerzan L, Olteanu A, Maniu I, et al.. Thrombin generation in chronic liver diseases - a pilot study. Healthcare (Basel). 2021, 9:550. 10.3390\/healthcare9050550","journal-title":"Healthcare (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(17)33853-2","article-title":"Real life experience with Ombitasvir\/Paritaprevir\/Ritonavir + Dasabuvir and Ribavirin regimen in patients with compensated HCV cirrhosis","volume":"152","author":"Jinga M","year":"2017","unstructured":"Jinga M, Balaban VD, Ioni\u021b\u0103 Radu F, Costache RS. Real life experience with Ombitasvir\/Paritaprevir\/Ritonavir + Dasabuvir and Ribavirin regimen in patients with compensated HCV cirrhosis. Gastroenterology. 2017, 152:S1148. 10.1016\/S0016-5085(17)33853-2","journal-title":"Gastroenterology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13374","article-title":"Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis","volume":"37","author":"Tripodi A","year":"2017","unstructured":"Tripodi A, D'Ambrosio R, Padovan L, et al.. Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis. Liver Int. 2017, 37:1295-303. 10.1111\/liv.13374","journal-title":"Liver Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi A","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005, 41:553-8. 10.1002\/hep.20569","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.01.015","article-title":"Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research","volume":"46","author":"Tripodi A","year":"2007","unstructured":"Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol. 2007, 46:727-33. 10.1016\/j.jhep.2007.01.015","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2014.00031","article-title":"Thrombosis associated with viral hepatitis","volume":"2","author":"Galli L","year":"2014","unstructured":"Galli L, Gerdes VE, Guasti L, Squizzato A. Thrombosis associated with viral hepatitis. J Clin Transl Hepatol. 2014, 2:234-9. 10.14218\/JCTH.2014.00031","journal-title":"J Clin Transl Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy","volume":"8","author":"Gatt A","year":"2010","unstructured":"Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost. 2010, 8:1994-2000. 10.1111\/j.1538-7836.2010.03937.x","journal-title":"J Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/299432-correlation-between-thrombin-generation-and-hepatic-fibrosis-in-chronic-liver-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T20:08:55Z","timestamp":1728850135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/299432-correlation-between-thrombin-generation-and-hepatic-fibrosis-in-chronic-liver-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,13]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.71376","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,13]]}}}